Physicochemical properties and blood compatibility of acylated chitosan nanoparticles

Carbohydrate Polymers

Volumn 58, Issue 4, 2004, Pages 371-377

  Lee, Dong Won ^a   Powers, Kevin ^b   Baney, Ronald ^a  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Acylation; Chitosan nanoparticles; Degree of substitution; Hemolysis; Thromboelastography

Indexed keywords

ACYLATION; AGGLOMERATION; BLOOD; DRYING; HYDROGEN BONDS; METHANOL; POLYMERS; SUBSTITUTION REACTIONS;

CHITOSAN NANOPARTICLES; DEGREE OF SUBSTITUTION; HEMOLYSIS; THROMBOELSTOGRAPHY;

NANOSTRUCTURED MATERIALS;

EID: 9644281090     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2004.06.033     Document Type: Article

References (31)

1. Berthold, A., Cremer, K., & Kreuter, J. (1996). Preparation and characterization of chitosan microspheres as drug carrier for prednidolone sodium phosphate as model for anti-inflammatory drugs. Journal of Controlled Release, 39, 17-25.
2. Calvo, P., Remunan-Lopez, C., Vila-Jato, J. L., & Alonso, M. J. (1997). Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. Journal of Applied Polymer Science, 63, 125-132.
3. Fernandez-Urrasuno, R., Romani, D., Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1999). Development of a freeze-dried formulation of insulinloaded chitosan nanoparticles intended for nasal administration. STP Pharma Science, 5, 429-436.
4. Gaur, U., Sahoo, S. K., De, T. K., Ghosh, P. C., Maitra, A., & Ghosh, P. K. (2000). Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. International Journal of Pharmaceutics, 202, 1-10.
5. Hirano, S., Noishiki, Y., & Kinugawa, J. (1985). Chitin and chitosan for use as novel biomaterials Abstract of Papers of the American Chemical Society, 190, 130-PME.
6. Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y., & Yang, C. (2002). Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials, 23, 3193-3201.
7. Illum, L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharmaceutical Research, 15, 1326-1331.
8. Illum, L., & Davis, S. S. (1983). Effect of the nonionic surfactant Poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. Journal of Pharmaceutical Science, 72, 1086-1089.
9. Janes, K. A., Calvo, P., & Alonso, M. J. (2001). Polysaccharide colloidal particles as delivery systems for macromolecules. Advanced Drug Delivery Review, 47, 83-97.
10. Jumaa, M., Furkert, F. H., & Muller, B. W. (2002). A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. European Journal of Pharmaceutics and Biopharmaceutics, 53, 115-123.
11. Kumar, M. N. V. R. (2000). A review of chitin and chitosan application. Reactive and Functional Polymers, 46, 1-27.
12. Kurita, K. (2001). Controlled functionalization of the polysaccharide chitin. Progress in Polymer Science, 26, 1921-1971.
13. Lee, D.-W., & Baney, R. H. (2004). Detoxification of amitriptyline by oligochitosan derivatives. Biotechnology Letters, 26, 713-716.
14. Lee, K. Y., Ha, W. S., & Park, W. H. (1995). Blood compatibility and biodegradability of partially W-acylated chitosan derivatives. Biomaterials, 16, 1211-1216.
15. Leong, K. W., Mao, H. Q., Truong-Le, V. L., Roy, K., Walsh, S. M., & August, J. T. (1998). DNA-polycation nanospheres as nonviral gene delivery vehicles. Journal of Controlled Release, 53, 183-193.
16. MacLaughlin, F. C., Mumper, R. J., Wang, J., Tagliferri, J. M., Gill, I., Hinchcliffe, M., & Rolland, A. P. (1998). Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. Journal of Controlled Release, 56, 259-272.
17. Mi, F. L., Tan, Y. C., Liang, H. F., & Sung, H. W. (2002). In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials, 23, 181-191.
18. Morey, T. E., Varshney, M., Flint, J. A., Rajasekaran, S., Shah, D. O., & Dennis, D. M. (2004). Treatment of local anesthetic-induced cardiotoxicity using drug scavenging nanoparticles. Nano Letters, 4, 757-759.
19. Oungbho, K., & Muller, B. W. (1997). Chitosan sponges as sustained release drug carriers. International Journal of Pharmaceutics, 156, 229-237.
20. Pesko, L. J. (1996). Physiological consequences of injected particulates. In J. Z. Knapp, T. A. Barber, & A. Liebermn (Eds.), Liquid-and surface-borne particle measurement handbook. New York: Marcel Dekker.
21. Rao, S. B., & Sharma, C. P. (1997). Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. Journal of Biomedical Materials Research, 34, 21-28.
22. Remunan-Lopez, C., & Bodmeier, R. (1996). Effect of formulation and process variables on the formation of chitosan-gelatin coacervatives. International Journal of Pharmaceutics, 135, 63-72.
23. Richardson, S. C. W., Kolbe, H. V. J., & Duncan, R. (1999). Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. International Journal of Pharmaceutics, 178, 231-243.
24. Schipper, N. G. M., Varum, K. M., & Artursson, P. (1996). Chitosans as absorption enhancers for poorly absorbable drugs. 1. Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial(Caco-2) cells. Pharmaceutical Research, 13, 1686-1692.
25. Shu, X. Z., & Zhu, K. J. (2000). A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. International Journal of Pharmaceutics, 201, 51-58.
26. Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995). Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Advanced Drug Delivery Review, 17, 31-48.
27. Tobias, M. D., Henry, C., & Augostides, Y. G. T. (1999). Lidocaine and bupivacaine exert differential effects on whole blood coagulation. Journal of Clinical Anesthesia, 11, 52-55.
28. Underbill, R. S., Jovanovi, A. V., Carino, S. R., Varshney, M., Shah, D., Dennis, D. M., Morey, T. E., & Duran, R. S. (2002). Oil-filled silica nanocapsules for lipophilic drug uptake: implication for drug detoxification therapy. Chemistry of Materials, 14, 4919-4925.
29. van der Lubben, I. M., Varhoef, J. C., van Aelst, A. C., Borchard, G., & Junginger, H. E. (2001). Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials, 22, 687-694.
30. Wenker, O. C., Wojciechowski, Z., Sheinbaum, R., & Zisman, E. (2000). Thromboelastography. Internet Journal of Anesthesiology, 1.
31. Yoksan, R., Aksshi, M., Biramontri, S., & Chirachachai, S. (2001). Hydrophobic chain conjugation at hydroxyl group onto γ-ray irradiation chitosan. Biomacromolecules, 2, 1038-1044.